DE60017399D1 - Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung - Google Patents

Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung

Info

Publication number
DE60017399D1
DE60017399D1 DE60017399T DE60017399T DE60017399D1 DE 60017399 D1 DE60017399 D1 DE 60017399D1 DE 60017399 T DE60017399 T DE 60017399T DE 60017399 T DE60017399 T DE 60017399T DE 60017399 D1 DE60017399 D1 DE 60017399D1
Authority
DE
Germany
Prior art keywords
homoerythromyine
deoxo
aza
derivative
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60017399T
Other languages
English (en)
Other versions
DE60017399T2 (de
Inventor
Robert John Rafka
Colman Brendan Ragan
Douglas John Meldrum Allen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE60017399D1 publication Critical patent/DE60017399D1/de
Application granted granted Critical
Publication of DE60017399T2 publication Critical patent/DE60017399T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60017399T 1999-06-30 2000-06-13 Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung Expired - Fee Related DE60017399T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14168199P 1999-06-30 1999-06-30
US141681P 1999-06-30
PCT/IB2000/000785 WO2001002414A1 (en) 1999-06-30 2000-06-13 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE60017399D1 true DE60017399D1 (de) 2005-02-17
DE60017399T2 DE60017399T2 (de) 2006-03-30

Family

ID=22496734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017399T Expired - Fee Related DE60017399T2 (de) 1999-06-30 2000-06-13 Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung

Country Status (42)

Country Link
US (3) US6465437B1 (de)
EP (1) EP1189913B1 (de)
JP (1) JP2003503506A (de)
KR (1) KR100442508B1 (de)
CN (2) CN101220067A (de)
AP (1) AP2001002370A0 (de)
AR (1) AR035551A1 (de)
AT (1) ATE286906T1 (de)
AU (1) AU772277B2 (de)
BG (1) BG65587B1 (de)
BR (1) BR0012091A (de)
CA (1) CA2376748C (de)
CO (1) CO5190679A1 (de)
CZ (1) CZ20014571A3 (de)
DE (1) DE60017399T2 (de)
EA (1) EA004235B1 (de)
EC (1) ECSP003555A (de)
EE (1) EE05068B1 (de)
ES (1) ES2233380T3 (de)
GT (2) GT200000105A (de)
HN (1) HN2000000090A (de)
HR (1) HRP20010919B1 (de)
HU (1) HUP0201693A3 (de)
IL (1) IL146408A0 (de)
IS (1) IS6159A (de)
MA (1) MA26745A1 (de)
MX (1) MXPA02000058A (de)
MY (1) MY133360A (de)
NO (1) NO20016221L (de)
OA (1) OA11965A (de)
PA (1) PA8496901A1 (de)
PE (1) PE20010287A1 (de)
PL (1) PL201891B1 (de)
PT (1) PT1189913E (de)
SK (1) SK286243B6 (de)
TN (1) TNSN00143A1 (de)
TR (1) TR200103834T2 (de)
UA (1) UA71013C2 (de)
UY (1) UY26221A1 (de)
WO (1) WO2001002414A1 (de)
YU (1) YU88701A (de)
ZA (1) ZA200110453B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6791660B1 (en) * 2002-02-12 2004-09-14 Seiko Epson Corporation Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN110885351A (zh) * 2019-12-17 2020-03-17 海门慧聚药业有限公司 泰拉霉素磷酸盐的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
OA11876A (en) * 1999-05-18 2006-03-27 Pfizer Prod Inc Novel crystalline forms of a macrolide antibiotic.
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

Also Published As

Publication number Publication date
KR20020016875A (ko) 2002-03-06
EP1189913A1 (de) 2002-03-27
US20040209826A1 (en) 2004-10-21
NO20016221D0 (no) 2001-12-19
HRP20010919B1 (en) 2005-06-30
PE20010287A1 (es) 2001-03-05
CN101220067A (zh) 2008-07-16
AR035551A1 (es) 2004-06-16
UA71013C2 (uk) 2004-11-15
EA200101178A1 (ru) 2002-06-27
NO20016221L (no) 2001-12-19
ATE286906T1 (de) 2005-01-15
PA8496901A1 (es) 2002-08-26
HUP0201693A2 (en) 2002-10-28
CA2376748A1 (en) 2001-01-11
GT200000105AA (es) 2001-12-20
EP1189913B1 (de) 2005-01-12
US6465437B1 (en) 2002-10-15
CO5190679A1 (es) 2002-08-29
YU88701A (sh) 2004-09-03
MXPA02000058A (es) 2002-07-02
PT1189913E (pt) 2005-04-29
OA11965A (en) 2006-04-12
IS6159A (is) 2001-11-13
TR200103834T2 (tr) 2002-05-21
AP2001002370A0 (en) 2001-12-31
ECSP003555A (es) 2002-01-25
ES2233380T3 (es) 2005-06-16
JP2003503506A (ja) 2003-01-28
PL201891B1 (pl) 2009-05-29
EA004235B1 (ru) 2004-02-26
ZA200110453B (en) 2003-03-04
US7297682B2 (en) 2007-11-20
KR100442508B1 (ko) 2004-07-30
GT200000105A (es) 2001-12-20
EE200100699A (et) 2003-02-17
SK18922001A3 (sk) 2002-04-04
IL146408A0 (en) 2002-07-25
AU772277B2 (en) 2004-04-22
CN1358188A (zh) 2002-07-10
BR0012091A (pt) 2002-04-02
HN2000000090A (es) 2001-04-20
WO2001002414A1 (en) 2001-01-11
US20030092642A1 (en) 2003-05-15
MY133360A (en) 2007-11-30
MA26745A1 (fr) 2004-12-20
TNSN00143A1 (fr) 2005-11-10
CZ20014571A3 (cs) 2002-04-17
PL352900A1 (en) 2003-09-22
BG106123A (en) 2002-05-31
DE60017399T2 (de) 2006-03-30
AU4943900A (en) 2001-01-22
CA2376748C (en) 2006-03-14
EE05068B1 (et) 2008-08-15
HUP0201693A3 (en) 2003-03-28
SK286243B6 (sk) 2008-06-06
BG65587B1 (bg) 2009-01-30
HRP20010919A2 (en) 2003-02-28
US6861412B2 (en) 2005-03-01
UY26221A1 (es) 2001-01-31

Similar Documents

Publication Publication Date Title
DE59910858D1 (de) Pharmazeutische zubereitung von moxifloxacin
DE69801045T2 (de) Pharmazeutische zusammensetzung zur oralen verabreichung von einem n-piperidin-3-pyrazolcarboxamid-derivat, dessen salzen und deren solvaten
DE69629988D1 (de) Pharmazeutisches Grundbestandteil und seine Verwendung
IS5245A (is) Lyfjablanda úr ómeprasól
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
DE69910186D1 (de) Pharmazeutische zusammensetzung von topiramate
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
DE69325408D1 (de) Pharmazeutische Zubereitung in wässriger Suspensionsform
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
DE59813619D1 (de) Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
PT918059E (pt) Derivados substituidos de imidazolidina a sua sintese a sua utilizacao e preparacoes farmaceuticas contendo os mesmos
DE60039598D1 (de) Pharmazeutische zusammensetzungen von erythropoietin
DE60035581D1 (de) Salz von amlodipin und atorvastatin
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
FI970058A (fi) Uusi suun kautta annettava farmaseuttinen valmiste, joka sisältää omepratsolin magnesiumsuolaa
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
PT1202996E (pt) Compostos de titanio a sua preparacao e a sua utilizacao
DE60017399D1 (de) Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung
NO973610D0 (no) Nytt farmasöytisk preparat
DE69806353D1 (de) Pyrrolo[3,2-c]chinolin-derivate, die eine haloalkoxy-gruppe enthalten und ihre pharmazeutisch verträglichen salze
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
NO973611D0 (no) Nytt farmasöytisk preparat
DE50011647D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
SI1189913T1 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee